Navigation Links
Swedish Biotech Licenses HIV Drug to China for Development

The Swedish biotechnology company Medivir announced yesterday that it has licensed its experimental non-nucleoside// reverse transcriptase inhibitor (NNRTI), code-named MIV-160, to the Chinese company Guangdong Lantai Viewland Pharmaceutical for the China region. Medivir will retain the worldwide rights to the product.

Guangdong Lantai Viewland Pharmaceutical will potentially develop MIV-160 for three different products; an oral treatment regime, a vaginal microbicide and coating of condoms. It is the first antiretroviral product to be investigated as an additive agent to condom lubrication.

Professor Bo Oberg, head of the HIV franchise at Medivir, told aidsmap: 'This should enhance the safety of condoms and will at least save a few infections.'

MIV-160 is also an attractive microbicide product, he said, because it can inhibit HIV at very low concentrations – several thousand times lower than products currently being investigated in phase III trials in Africa. A second Medivir NNRTI – MIV-150 – is being investigated in combination with the microbicide Carraguard in a phase I study.

Medivir says that MIV-160, still in pre-clinical development, has shown good activity against NNRTI-resistant virus.

It is the first time that a Chinese company has won the global rights to develop an HIV product. Prof. Oberg said that Medivir will retain the right to commercialise or license any developments that result from the partnership for the rest of the world.

Medivir is also involved in two other development partnerships, with Tibotec for an HIV protease inhibitor and a nucleoside analogue, and with Bristol Myers Squibb for the NNRTI MIV-170.

Source-Bio-Bio Technology
SM
'"/>




Page: 1

Related medicine news :

1. Sick Swedish seagull was drunk, not affected by bird flu
2. GE Healthcare to Acquire Swedish Medical Company
3. Biotechnology industry expected to grow into a three billion dollar industry by 2002
4. Biotechnology on the lead
5. Panacea Biotech To Market Anthrax Vaccine
6. Commercialization of Biotech Discoveries, An Encouragement For Researchers
7. Biotech drug causing anemia-EPREX
8. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
9. Biologicals Transfer Proposal between US and Indian Biotechnology
10. Vical Biotech and NIH jointly develops HIV vaccine
11. Biotechnology Initiatives Planned In Hyderabad
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... Milford, PA (PRWEB) , ... May 02, 2016 , ... ... now available at MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. “Patients ... the office, have their unwanted fat treated and go home or back to work ...
(Date:5/1/2016)... (PRWEB) , ... May 02, 2016 , ... ... search for original 1968 Jimi Hendrix Merriweather Post Pavilion in Columbia, Maryland concert ... Hendrix concert poster. The concert was held on August 16. According to Hawley, ...
(Date:5/1/2016)... ... , ... Good Circle Insurance Agency of Mission Viejo, California recently introduced a ... verity of health, life and injury policies and this new plan allows coverage for ... insurance plans don’t cover chiropractic care, so we decided to create this new plan ...
(Date:4/30/2016)... ... April 30, 2016 , ... Saturday, April ... veterinarians’ global impact on public health. The World Veterinary Association (WVA) and the ... year have selected continuing education with a One Health focus, which emphasizes how ...
(Date:4/29/2016)... ... April 30, 2016 , ... ... products, announces the Pick Up Springboard, an automotive invention that improves the storage ... industry is worth $162 billion," says Scott Cooper, CEO and Creative Director of ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/28/2016)... Mich. , April 28, 2016   ... . Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... has signed a definitive agreement to acquire Valley ... Specialty Pharmacy ("TNH"), a leading specialty pharmacy that ... Van Nuys, California . In 2015, TNH ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
Breaking Medicine Technology: